Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.6 SEK | -0.29% |
|
0.00% | +61.76% |
Jul. 05 | European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading | MT |
Jul. 05 | Calliditas Therapeutics' Partner Launches Japanese Trial for IgA Nephropathy Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.76% | 1.06B | |
+5.90% | 71.83B | |
+22.78% | 9.56B | |
+30.09% | 4.85B | |
-21.31% | 4.48B | |
+24.78% | 3.9B | |
+11.03% | 2.01B | |
-2.11% | 1.99B | |
-36.28% | 1.89B | |
-43.19% | 1.77B |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- HC Wainwright Downgrades Calliditas Therapeutics to Neutral From Buy, Cuts Price Target to $39 From $45